Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

Most patients treated with low-dose alpha-interferon for malignant melanoma experienced skin side effects, with hair loss being the most frequent.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

The document concludes that recognizing and properly diagnosing lipodystrophy syndromes is crucial for effective management and treatment.

Chemotherapy can cause various skin problems, and recognizing them helps improve patient care.

The conclusion is that acne, alopecia, and hyperhidrosis are common skin issues with various treatments available, and accurate diagnosis is key for effective management.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

Minoxidil doesn't increase pericardial disorder risk, but may cause fluid accumulation.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

Hair follicles offer promising targets for delivering drugs to treat hair and skin conditions.

Exosomes can improve skin health and offer new treatments for skin repair and rejuvenation.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Minoxidil works in liver and outer hair root sheath for hair growth.

The VQ-Dermato is a reliable French questionnaire for measuring quality of life in chronic skin disorder patients.

Thyroid hormone affects skin health, with too little causing rough, pale skin and too much leading to smooth, thin skin, and may also impact wound healing and skin conditions.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Black dots under trichoscopy can appear in different hair and scalp conditions, not just in alopecia areata.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

Men with Frontal fibrosing alopecia typically lose hair on the front scalp and sometimes on sideburns and upper lip, with treatments showing varied success.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Bee venom might be a good alternative treatment for various skin conditions because it has many healing properties.

Gene therapy has potential as a future treatment for Hutchinson-Gilford progeria syndrome.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

Injection lipolysis effectively reduces small fat deposits and should be done with care and proper patient selection.

Most patients with Porphyria Cutanea Tarda had skin blisters and were often affected by hepatitis C and alcohol abuse, with differences between familial and sporadic cases.

A woman with breast cancer developed a rare condition causing excessive fine hair growth on her face and body.

Short anagen syndrome involves a hair growth phase lasting 1.5 years.

Prostaglandin E2 affects human platelet activity in complex ways that could lead to personalized heart disease treatments.